Private equity investment committee proposal - medpace capital structure
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/156165 |
Resumo: | Medpace is one of the world’s leading Contract Research Organizations, by revenue, and it differentiates itself by focusing on full-service clinical trials for small and mid-sized biopharma clients. Its strong positioning in a niche market, the high projected industry growth, its strong and stable FCFs, and experienced management team make it an ideal target, which would be further improved by our developed business plan that will enhance its operations, expand internationally, and capitalize on M&A trends. Our proposed transaction is expected to deliver a money multiple of 3.28x and an IRR of 26.84%, representing a strong investment opportunity. |
id |
RCAP_a23b71c71eedbfc37a3199b7ded370c6 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/156165 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Private equity investment committee proposal - medpace capital structureContract research organisation (Cro)Mergers & acquisitions (M&A)BiopharmaLeveraged buyoutMoney multiple (Mm)Internal rate of return (Irr)Domínio/Área Científica::Ciências Sociais::Economia e GestãoMedpace is one of the world’s leading Contract Research Organizations, by revenue, and it differentiates itself by focusing on full-service clinical trials for small and mid-sized biopharma clients. Its strong positioning in a niche market, the high projected industry growth, its strong and stable FCFs, and experienced management team make it an ideal target, which would be further improved by our developed business plan that will enhance its operations, expand internationally, and capitalize on M&A trends. Our proposed transaction is expected to deliver a money multiple of 3.28x and an IRR of 26.84%, representing a strong investment opportunity.Duarte, Luís MotaSantos, FábioRUNDias, José António Moreira Braga Almeida2023-08-02T11:42:32Z2023-01-132023-01-102023-01-13T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/156165TID:203311906enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:38:46Zoai:run.unl.pt:10362/156165Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:56:21.979600Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Private equity investment committee proposal - medpace capital structure |
title |
Private equity investment committee proposal - medpace capital structure |
spellingShingle |
Private equity investment committee proposal - medpace capital structure Dias, José António Moreira Braga Almeida Contract research organisation (Cro) Mergers & acquisitions (M&A) Biopharma Leveraged buyout Money multiple (Mm) Internal rate of return (Irr) Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
title_short |
Private equity investment committee proposal - medpace capital structure |
title_full |
Private equity investment committee proposal - medpace capital structure |
title_fullStr |
Private equity investment committee proposal - medpace capital structure |
title_full_unstemmed |
Private equity investment committee proposal - medpace capital structure |
title_sort |
Private equity investment committee proposal - medpace capital structure |
author |
Dias, José António Moreira Braga Almeida |
author_facet |
Dias, José António Moreira Braga Almeida |
author_role |
author |
dc.contributor.none.fl_str_mv |
Duarte, Luís Mota Santos, Fábio RUN |
dc.contributor.author.fl_str_mv |
Dias, José António Moreira Braga Almeida |
dc.subject.por.fl_str_mv |
Contract research organisation (Cro) Mergers & acquisitions (M&A) Biopharma Leveraged buyout Money multiple (Mm) Internal rate of return (Irr) Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
topic |
Contract research organisation (Cro) Mergers & acquisitions (M&A) Biopharma Leveraged buyout Money multiple (Mm) Internal rate of return (Irr) Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
description |
Medpace is one of the world’s leading Contract Research Organizations, by revenue, and it differentiates itself by focusing on full-service clinical trials for small and mid-sized biopharma clients. Its strong positioning in a niche market, the high projected industry growth, its strong and stable FCFs, and experienced management team make it an ideal target, which would be further improved by our developed business plan that will enhance its operations, expand internationally, and capitalize on M&A trends. Our proposed transaction is expected to deliver a money multiple of 3.28x and an IRR of 26.84%, representing a strong investment opportunity. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-08-02T11:42:32Z 2023-01-13 2023-01-10 2023-01-13T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/156165 TID:203311906 |
url |
http://hdl.handle.net/10362/156165 |
identifier_str_mv |
TID:203311906 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138149185617920 |